nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—CYP1A2—type 2 diabetes mellitus	0.14	0.602	CbGaD
Lansoprazole—CYP3A4—type 2 diabetes mellitus	0.0926	0.398	CbGaD
Lansoprazole—CYP2C18—Tolbutamide—type 2 diabetes mellitus	0.0497	0.103	CbGbCtD
Lansoprazole—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0185	0.0383	CbGbCtD
Lansoprazole—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0148	0.0307	CbGbCtD
Lansoprazole—ABCB1—Linagliptin—type 2 diabetes mellitus	0.014	0.0291	CbGbCtD
Lansoprazole—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.0134	0.0277	CbGbCtD
Lansoprazole—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0132	0.0274	CbGbCtD
Lansoprazole—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0129	0.0267	CbGbCtD
Lansoprazole—ABCG2—Glyburide—type 2 diabetes mellitus	0.0128	0.0266	CbGbCtD
Lansoprazole—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0125	0.026	CbGbCtD
Lansoprazole—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0123	0.0256	CbGbCtD
Lansoprazole—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.0119	0.0247	CbGbCtD
Lansoprazole—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0118	0.0245	CbGbCtD
Lansoprazole—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0112	0.0233	CbGbCtD
Lansoprazole—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0112	0.0233	CbGbCtD
Lansoprazole—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.011	0.0227	CbGbCtD
Lansoprazole—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0103	0.0215	CbGbCtD
Lansoprazole—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.00999	0.0207	CbGbCtD
Lansoprazole—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.00971	0.0201	CbGbCtD
Lansoprazole—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.00955	0.0198	CbGbCtD
Lansoprazole—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.00932	0.0193	CbGbCtD
Lansoprazole—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.00932	0.0193	CbGbCtD
Lansoprazole—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00905	0.0188	CbGbCtD
Lansoprazole—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.0086	0.0178	CbGbCtD
Lansoprazole—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.00852	0.0177	CbGbCtD
Lansoprazole—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.00841	0.0174	CbGbCtD
Lansoprazole—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.00831	0.0172	CbGbCtD
Lansoprazole—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.00787	0.0163	CbGbCtD
Lansoprazole—CYP2C9—Valsartan—type 2 diabetes mellitus	0.0076	0.0158	CbGbCtD
Lansoprazole—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00752	0.0156	CbGbCtD
Lansoprazole—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0075	0.0156	CbGbCtD
Lansoprazole—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00711	0.0147	CbGbCtD
Lansoprazole—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00706	0.0147	CbGbCtD
Lansoprazole—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00686	0.0142	CbGbCtD
Lansoprazole—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00677	0.014	CbGbCtD
Lansoprazole—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00646	0.0134	CbGbCtD
Lansoprazole—CYP2C8—Losartan—type 2 diabetes mellitus	0.00626	0.013	CbGbCtD
Lansoprazole—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00621	0.0129	CbGbCtD
Lansoprazole—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00619	0.0128	CbGbCtD
Lansoprazole—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00599	0.0124	CbGbCtD
Lansoprazole—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00574	0.0119	CbGbCtD
Lansoprazole—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.00542	0.0112	CbGbCtD
Lansoprazole—CYP2C19—Losartan—type 2 diabetes mellitus	0.00525	0.0109	CbGbCtD
Lansoprazole—CYP1A2—Losartan—type 2 diabetes mellitus	0.00484	0.01	CbGbCtD
Lansoprazole—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00477	0.0099	CbGbCtD
Lansoprazole—ABCB1—Glyburide—type 2 diabetes mellitus	0.00463	0.00961	CbGbCtD
Lansoprazole—CYP2C9—Losartan—type 2 diabetes mellitus	0.00436	0.00905	CbGbCtD
Lansoprazole—ABCB1—Losartan—type 2 diabetes mellitus	0.00424	0.00879	CbGbCtD
Lansoprazole—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00411	0.00852	CbGbCtD
Lansoprazole—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00394	0.00817	CbGbCtD
Lansoprazole—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00394	0.00817	CbGbCtD
Lansoprazole—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00372	0.00773	CbGbCtD
Lansoprazole—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00277	0.00576	CbGbCtD
Lansoprazole—CYP3A4—Losartan—type 2 diabetes mellitus	0.00254	0.00526	CbGbCtD
Lansoprazole—MAPT—retina—type 2 diabetes mellitus	0.00128	0.0787	CbGeAlD
Lansoprazole—MAPT—nephron tubule—type 2 diabetes mellitus	0.00121	0.0741	CbGeAlD
Lansoprazole—ATP4B—liver—type 2 diabetes mellitus	0.00114	0.0702	CbGeAlD
Lansoprazole—MAPT—cortex of kidney—type 2 diabetes mellitus	0.00103	0.0634	CbGeAlD
Lansoprazole—CYP4A11—kidney—type 2 diabetes mellitus	0.000978	0.06	CbGeAlD
Lansoprazole—Thiabendazole—CYP1A2—type 2 diabetes mellitus	0.000974	0.289	CrCbGaD
Lansoprazole—MAPT—adipose tissue—type 2 diabetes mellitus	0.000957	0.0587	CbGeAlD
Lansoprazole—CYP4A11—cortex of kidney—type 2 diabetes mellitus	0.000953	0.0584	CbGeAlD
Lansoprazole—ATP4A—cardiovascular system—type 2 diabetes mellitus	0.000806	0.0494	CbGeAlD
Lansoprazole—ATP4A—kidney—type 2 diabetes mellitus	0.000788	0.0484	CbGeAlD
Lansoprazole—Omeprazole—CYP11A1—type 2 diabetes mellitus	0.000681	0.202	CrCbGaD
Lansoprazole—CYP4A11—liver—type 2 diabetes mellitus	0.000618	0.0379	CbGeAlD
Lansoprazole—ATP4A—liver—type 2 diabetes mellitus	0.000498	0.0306	CbGeAlD
Lansoprazole—CYP2C18—liver—type 2 diabetes mellitus	0.00041	0.0251	CbGeAlD
Lansoprazole—CYP1B1—nephron tubule—type 2 diabetes mellitus	0.000357	0.0219	CbGeAlD
Lansoprazole—CYP1B1—cardiovascular system—type 2 diabetes mellitus	0.000321	0.0197	CbGeAlD
Lansoprazole—CYP1B1—kidney—type 2 diabetes mellitus	0.000314	0.0193	CbGeAlD
Lansoprazole—Rabeprazole—CYP1A2—type 2 diabetes mellitus	0.000307	0.091	CrCbGaD
Lansoprazole—Pantoprazole—CYP1A2—type 2 diabetes mellitus	0.000307	0.091	CrCbGaD
Lansoprazole—CYP1B1—cortex of kidney—type 2 diabetes mellitus	0.000306	0.0187	CbGeAlD
Lansoprazole—CYP1B1—adipose tissue—type 2 diabetes mellitus	0.000283	0.0173	CbGeAlD
Lansoprazole—Esomeprazole—CYP3A4—type 2 diabetes mellitus	0.000281	0.0833	CrCbGaD
Lansoprazole—ABCG2—nephron tubule—type 2 diabetes mellitus	0.000266	0.0163	CbGeAlD
Lansoprazole—Omeprazole—CYP1A2—type 2 diabetes mellitus	0.00025	0.0741	CrCbGaD
Lansoprazole—CYP2C8—kidney—type 2 diabetes mellitus	0.00024	0.0147	CbGeAlD
Lansoprazole—CYP1A1—kidney—type 2 diabetes mellitus	0.000222	0.0136	CbGeAlD
Lansoprazole—CYP2C9—cardiovascular system—type 2 diabetes mellitus	0.000218	0.0134	CbGeAlD
Lansoprazole—ABCG2—adipose tissue—type 2 diabetes mellitus	0.000211	0.0129	CbGeAlD
Lansoprazole—Pantoprazole—CYP3A4—type 2 diabetes mellitus	0.000203	0.0602	CrCbGaD
Lansoprazole—Rabeprazole—CYP3A4—type 2 diabetes mellitus	0.000203	0.0602	CrCbGaD
Lansoprazole—CYP1A1—adipose tissue—type 2 diabetes mellitus	0.0002	0.0123	CbGeAlD
Lansoprazole—CYP1B1—liver—type 2 diabetes mellitus	0.000198	0.0122	CbGeAlD
Lansoprazole—CYP2C19—liver—type 2 diabetes mellitus	0.000174	0.0107	CbGeAlD
Lansoprazole—Omeprazole—CYP3A4—type 2 diabetes mellitus	0.000165	0.0491	CrCbGaD
Lansoprazole—ABCB1—islet of Langerhans—type 2 diabetes mellitus	0.000163	0.00999	CbGeAlD
Lansoprazole—CYP3A4—kidney—type 2 diabetes mellitus	0.000163	0.00999	CbGeAlD
Lansoprazole—CYP2D6—kidney—type 2 diabetes mellitus	0.00016	0.00983	CbGeAlD
Lansoprazole—CYP2C8—liver—type 2 diabetes mellitus	0.000152	0.00932	CbGeAlD
Lansoprazole—ABCG2—liver—type 2 diabetes mellitus	0.000148	0.00906	CbGeAlD
Lansoprazole—CYP1A2—liver—type 2 diabetes mellitus	0.000142	0.00872	CbGeAlD
Lansoprazole—CYP1A1—liver—type 2 diabetes mellitus	0.00014	0.0086	CbGeAlD
Lansoprazole—ABCB1—retina—type 2 diabetes mellitus	0.000139	0.00854	CbGeAlD
Lansoprazole—CYP2C9—liver—type 2 diabetes mellitus	0.000135	0.00828	CbGeAlD
Lansoprazole—ABCB1—nephron tubule—type 2 diabetes mellitus	0.000131	0.00804	CbGeAlD
Lansoprazole—ABCB1—cardiovascular system—type 2 diabetes mellitus	0.000118	0.00722	CbGeAlD
Lansoprazole—ABCB1—kidney—type 2 diabetes mellitus	0.000115	0.00707	CbGeAlD
Lansoprazole—ABCB1—pancreas—type 2 diabetes mellitus	0.000114	0.00702	CbGeAlD
Lansoprazole—ABCB1—cortex of kidney—type 2 diabetes mellitus	0.000112	0.00688	CbGeAlD
Lansoprazole—ABCB1—adipose tissue—type 2 diabetes mellitus	0.000104	0.00637	CbGeAlD
Lansoprazole—CYP3A4—liver—type 2 diabetes mellitus	0.000103	0.00631	CbGeAlD
Lansoprazole—CYP2D6—liver—type 2 diabetes mellitus	0.000101	0.00621	CbGeAlD
Lansoprazole—ABCB1—liver—type 2 diabetes mellitus	7.28e-05	0.00447	CbGeAlD
Lansoprazole—Dyspnoea—Valsartan—type 2 diabetes mellitus	4.5e-05	0.000258	CcSEcCtD
Lansoprazole—Vertigo—Losartan—type 2 diabetes mellitus	4.49e-05	0.000258	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	4.49e-05	0.000258	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	4.49e-05	0.000258	CcSEcCtD
Lansoprazole—Somnolence—Valsartan—type 2 diabetes mellitus	4.48e-05	0.000258	CcSEcCtD
Lansoprazole—Syncope—Losartan—type 2 diabetes mellitus	4.48e-05	0.000258	CcSEcCtD
Lansoprazole—Paraesthesia—Orlistat—type 2 diabetes mellitus	4.47e-05	0.000257	CcSEcCtD
Lansoprazole—Leukopenia—Losartan—type 2 diabetes mellitus	4.47e-05	0.000257	CcSEcCtD
Lansoprazole—Discomfort—Irbesartan—type 2 diabetes mellitus	4.47e-05	0.000257	CcSEcCtD
Lansoprazole—Skin disorder—Metformin—type 2 diabetes mellitus	4.46e-05	0.000256	CcSEcCtD
Lansoprazole—Immune system disorder—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000256	CcSEcCtD
Lansoprazole—Hyperhidrosis—Metformin—type 2 diabetes mellitus	4.44e-05	0.000255	CcSEcCtD
Lansoprazole—Dyspepsia—Valsartan—type 2 diabetes mellitus	4.44e-05	0.000255	CcSEcCtD
Lansoprazole—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	4.44e-05	0.000255	CcSEcCtD
Lansoprazole—Dizziness—Bromocriptine—type 2 diabetes mellitus	4.42e-05	0.000254	CcSEcCtD
Lansoprazole—Dry mouth—Irbesartan—type 2 diabetes mellitus	4.42e-05	0.000254	CcSEcCtD
Lansoprazole—Palpitations—Losartan—type 2 diabetes mellitus	4.42e-05	0.000254	CcSEcCtD
Lansoprazole—Nausea—Glimepiride—type 2 diabetes mellitus	4.4e-05	0.000253	CcSEcCtD
Lansoprazole—Arrhythmia—Ramipril—type 2 diabetes mellitus	4.4e-05	0.000253	CcSEcCtD
Lansoprazole—Loss of consciousness—Losartan—type 2 diabetes mellitus	4.39e-05	0.000252	CcSEcCtD
Lansoprazole—Nausea—Sitagliptin—type 2 diabetes mellitus	4.39e-05	0.000252	CcSEcCtD
Lansoprazole—Dyspepsia—Orlistat—type 2 diabetes mellitus	4.39e-05	0.000252	CcSEcCtD
Lansoprazole—Asthenia—Glyburide—type 2 diabetes mellitus	4.39e-05	0.000252	CcSEcCtD
Lansoprazole—Decreased appetite—Valsartan—type 2 diabetes mellitus	4.38e-05	0.000252	CcSEcCtD
Lansoprazole—Anorexia—Metformin—type 2 diabetes mellitus	4.38e-05	0.000252	CcSEcCtD
Lansoprazole—Cough—Losartan—type 2 diabetes mellitus	4.36e-05	0.000251	CcSEcCtD
Lansoprazole—Urticaria—Gliclazide—type 2 diabetes mellitus	4.36e-05	0.000251	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	4.35e-05	0.00025	CcSEcCtD
Lansoprazole—Alopecia—Ramipril—type 2 diabetes mellitus	4.35e-05	0.00025	CcSEcCtD
Lansoprazole—Fatigue—Valsartan—type 2 diabetes mellitus	4.35e-05	0.00025	CcSEcCtD
Lansoprazole—Body temperature increased—Gliclazide—type 2 diabetes mellitus	4.34e-05	0.000249	CcSEcCtD
Lansoprazole—Abdominal pain—Gliclazide—type 2 diabetes mellitus	4.34e-05	0.000249	CcSEcCtD
Lansoprazole—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	4.33e-05	0.000249	CcSEcCtD
Lansoprazole—Oedema—Irbesartan—type 2 diabetes mellitus	4.33e-05	0.000249	CcSEcCtD
Lansoprazole—Decreased appetite—Orlistat—type 2 diabetes mellitus	4.33e-05	0.000249	CcSEcCtD
Lansoprazole—Pruritus—Glyburide—type 2 diabetes mellitus	4.32e-05	0.000249	CcSEcCtD
Lansoprazole—Mental disorder—Ramipril—type 2 diabetes mellitus	4.31e-05	0.000248	CcSEcCtD
Lansoprazole—Constipation—Valsartan—type 2 diabetes mellitus	4.31e-05	0.000248	CcSEcCtD
Lansoprazole—Infection—Irbesartan—type 2 diabetes mellitus	4.31e-05	0.000247	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	4.3e-05	0.000247	CcSEcCtD
Lansoprazole—Fatigue—Orlistat—type 2 diabetes mellitus	4.3e-05	0.000247	CcSEcCtD
Lansoprazole—Hypotension—Metformin—type 2 diabetes mellitus	4.29e-05	0.000247	CcSEcCtD
Lansoprazole—Malnutrition—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000246	CcSEcCtD
Lansoprazole—Erythema—Ramipril—type 2 diabetes mellitus	4.28e-05	0.000246	CcSEcCtD
Lansoprazole—Shock—Irbesartan—type 2 diabetes mellitus	4.26e-05	0.000245	CcSEcCtD
Lansoprazole—Pain—Orlistat—type 2 diabetes mellitus	4.26e-05	0.000245	CcSEcCtD
Lansoprazole—Myalgia—Losartan—type 2 diabetes mellitus	4.25e-05	0.000245	CcSEcCtD
Lansoprazole—Chest pain—Losartan—type 2 diabetes mellitus	4.25e-05	0.000245	CcSEcCtD
Lansoprazole—Arthralgia—Losartan—type 2 diabetes mellitus	4.25e-05	0.000245	CcSEcCtD
Lansoprazole—Vomiting—Bromocriptine—type 2 diabetes mellitus	4.25e-05	0.000244	CcSEcCtD
Lansoprazole—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	4.25e-05	0.000244	CcSEcCtD
Lansoprazole—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	4.24e-05	0.000244	CcSEcCtD
Lansoprazole—Anxiety—Losartan—type 2 diabetes mellitus	4.24e-05	0.000244	CcSEcCtD
Lansoprazole—Tachycardia—Irbesartan—type 2 diabetes mellitus	4.23e-05	0.000243	CcSEcCtD
Lansoprazole—Rash—Bromocriptine—type 2 diabetes mellitus	4.22e-05	0.000242	CcSEcCtD
Lansoprazole—Dermatitis—Bromocriptine—type 2 diabetes mellitus	4.21e-05	0.000242	CcSEcCtD
Lansoprazole—Skin disorder—Irbesartan—type 2 diabetes mellitus	4.21e-05	0.000242	CcSEcCtD
Lansoprazole—Tension—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000242	CcSEcCtD
Lansoprazole—Discomfort—Losartan—type 2 diabetes mellitus	4.2e-05	0.000242	CcSEcCtD
Lansoprazole—Dysgeusia—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000241	CcSEcCtD
Lansoprazole—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	4.19e-05	0.000241	CcSEcCtD
Lansoprazole—Headache—Bromocriptine—type 2 diabetes mellitus	4.19e-05	0.000241	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	4.18e-05	0.000241	CcSEcCtD
Lansoprazole—Diarrhoea—Glyburide—type 2 diabetes mellitus	4.18e-05	0.00024	CcSEcCtD
Lansoprazole—Nervousness—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000239	CcSEcCtD
Lansoprazole—Dry mouth—Losartan—type 2 diabetes mellitus	4.16e-05	0.000239	CcSEcCtD
Lansoprazole—Anorexia—Irbesartan—type 2 diabetes mellitus	4.13e-05	0.000237	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	4.12e-05	0.000237	CcSEcCtD
Lansoprazole—Paraesthesia—Metformin—type 2 diabetes mellitus	4.12e-05	0.000237	CcSEcCtD
Lansoprazole—Muscle spasms—Ramipril—type 2 diabetes mellitus	4.12e-05	0.000237	CcSEcCtD
Lansoprazole—Confusional state—Losartan—type 2 diabetes mellitus	4.11e-05	0.000236	CcSEcCtD
Lansoprazole—Feeling abnormal—Orlistat—type 2 diabetes mellitus	4.11e-05	0.000236	CcSEcCtD
Lansoprazole—Dyspnoea—Metformin—type 2 diabetes mellitus	4.09e-05	0.000235	CcSEcCtD
Lansoprazole—Somnolence—Metformin—type 2 diabetes mellitus	4.08e-05	0.000235	CcSEcCtD
Lansoprazole—Oedema—Losartan—type 2 diabetes mellitus	4.08e-05	0.000234	CcSEcCtD
Lansoprazole—Anaphylactic shock—Losartan—type 2 diabetes mellitus	4.08e-05	0.000234	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	4.07e-05	0.000234	CcSEcCtD
Lansoprazole—Infection—Losartan—type 2 diabetes mellitus	4.05e-05	0.000233	CcSEcCtD
Lansoprazole—Hypotension—Irbesartan—type 2 diabetes mellitus	4.05e-05	0.000233	CcSEcCtD
Lansoprazole—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	4.04e-05	0.000232	CcSEcCtD
Lansoprazole—Dyspepsia—Metformin—type 2 diabetes mellitus	4.04e-05	0.000232	CcSEcCtD
Lansoprazole—Tremor—Ramipril—type 2 diabetes mellitus	4.01e-05	0.000231	CcSEcCtD
Lansoprazole—Shock—Losartan—type 2 diabetes mellitus	4.01e-05	0.000231	CcSEcCtD
Lansoprazole—Urticaria—Valsartan—type 2 diabetes mellitus	4.01e-05	0.00023	CcSEcCtD
Lansoprazole—Nervous system disorder—Losartan—type 2 diabetes mellitus	4e-05	0.00023	CcSEcCtD
Lansoprazole—Thrombocytopenia—Losartan—type 2 diabetes mellitus	3.99e-05	0.00023	CcSEcCtD
Lansoprazole—Decreased appetite—Metformin—type 2 diabetes mellitus	3.99e-05	0.000229	CcSEcCtD
Lansoprazole—Abdominal pain—Valsartan—type 2 diabetes mellitus	3.99e-05	0.000229	CcSEcCtD
Lansoprazole—Tachycardia—Losartan—type 2 diabetes mellitus	3.98e-05	0.000229	CcSEcCtD
Lansoprazole—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	3.98e-05	0.000229	CcSEcCtD
Lansoprazole—Nausea—Bromocriptine—type 2 diabetes mellitus	3.97e-05	0.000228	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	3.96e-05	0.000228	CcSEcCtD
Lansoprazole—Fatigue—Metformin—type 2 diabetes mellitus	3.96e-05	0.000228	CcSEcCtD
Lansoprazole—Urticaria—Orlistat—type 2 diabetes mellitus	3.96e-05	0.000228	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	3.95e-05	0.000227	CcSEcCtD
Lansoprazole—Hyperhidrosis—Losartan—type 2 diabetes mellitus	3.94e-05	0.000227	CcSEcCtD
Lansoprazole—Abdominal pain—Orlistat—type 2 diabetes mellitus	3.94e-05	0.000226	CcSEcCtD
Lansoprazole—Body temperature increased—Orlistat—type 2 diabetes mellitus	3.94e-05	0.000226	CcSEcCtD
Lansoprazole—Asthenia—Gliclazide—type 2 diabetes mellitus	3.94e-05	0.000226	CcSEcCtD
Lansoprazole—Agitation—Ramipril—type 2 diabetes mellitus	3.94e-05	0.000226	CcSEcCtD
Lansoprazole—Constipation—Metformin—type 2 diabetes mellitus	3.93e-05	0.000226	CcSEcCtD
Lansoprazole—Angioedema—Ramipril—type 2 diabetes mellitus	3.92e-05	0.000225	CcSEcCtD
Lansoprazole—Paraesthesia—Irbesartan—type 2 diabetes mellitus	3.89e-05	0.000224	CcSEcCtD
Lansoprazole—Anorexia—Losartan—type 2 diabetes mellitus	3.89e-05	0.000223	CcSEcCtD
Lansoprazole—Vomiting—Glyburide—type 2 diabetes mellitus	3.89e-05	0.000223	CcSEcCtD
Lansoprazole—Pruritus—Gliclazide—type 2 diabetes mellitus	3.88e-05	0.000223	CcSEcCtD
Lansoprazole—Malaise—Ramipril—type 2 diabetes mellitus	3.86e-05	0.000222	CcSEcCtD
Lansoprazole—Dyspnoea—Irbesartan—type 2 diabetes mellitus	3.86e-05	0.000222	CcSEcCtD
Lansoprazole—Rash—Glyburide—type 2 diabetes mellitus	3.85e-05	0.000222	CcSEcCtD
Lansoprazole—Somnolence—Irbesartan—type 2 diabetes mellitus	3.85e-05	0.000221	CcSEcCtD
Lansoprazole—Dermatitis—Glyburide—type 2 diabetes mellitus	3.85e-05	0.000221	CcSEcCtD
Lansoprazole—Vertigo—Ramipril—type 2 diabetes mellitus	3.85e-05	0.000221	CcSEcCtD
Lansoprazole—Syncope—Ramipril—type 2 diabetes mellitus	3.84e-05	0.000221	CcSEcCtD
Lansoprazole—Leukopenia—Ramipril—type 2 diabetes mellitus	3.84e-05	0.00022	CcSEcCtD
Lansoprazole—Headache—Glyburide—type 2 diabetes mellitus	3.83e-05	0.00022	CcSEcCtD
Lansoprazole—Dyspepsia—Irbesartan—type 2 diabetes mellitus	3.81e-05	0.000219	CcSEcCtD
Lansoprazole—Hypotension—Losartan—type 2 diabetes mellitus	3.81e-05	0.000219	CcSEcCtD
Lansoprazole—Palpitations—Ramipril—type 2 diabetes mellitus	3.79e-05	0.000218	CcSEcCtD
Lansoprazole—Feeling abnormal—Metformin—type 2 diabetes mellitus	3.78e-05	0.000218	CcSEcCtD
Lansoprazole—Decreased appetite—Irbesartan—type 2 diabetes mellitus	3.77e-05	0.000217	CcSEcCtD
Lansoprazole—Loss of consciousness—Ramipril—type 2 diabetes mellitus	3.77e-05	0.000216	CcSEcCtD
Lansoprazole—Diarrhoea—Gliclazide—type 2 diabetes mellitus	3.76e-05	0.000216	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	3.75e-05	0.000216	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.000215	CcSEcCtD
Lansoprazole—Cough—Ramipril—type 2 diabetes mellitus	3.74e-05	0.000215	CcSEcCtD
Lansoprazole—Fatigue—Irbesartan—type 2 diabetes mellitus	3.74e-05	0.000215	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	3.72e-05	0.000214	CcSEcCtD
Lansoprazole—Hypersensitivity—Valsartan—type 2 diabetes mellitus	3.72e-05	0.000214	CcSEcCtD
Lansoprazole—Convulsion—Ramipril—type 2 diabetes mellitus	3.71e-05	0.000213	CcSEcCtD
Lansoprazole—Constipation—Irbesartan—type 2 diabetes mellitus	3.71e-05	0.000213	CcSEcCtD
Lansoprazole—Pain—Irbesartan—type 2 diabetes mellitus	3.71e-05	0.000213	CcSEcCtD
Lansoprazole—Insomnia—Losartan—type 2 diabetes mellitus	3.69e-05	0.000212	CcSEcCtD
Lansoprazole—Hypersensitivity—Orlistat—type 2 diabetes mellitus	3.67e-05	0.000211	CcSEcCtD
Lansoprazole—Paraesthesia—Losartan—type 2 diabetes mellitus	3.66e-05	0.000211	CcSEcCtD
Lansoprazole—Urticaria—Metformin—type 2 diabetes mellitus	3.65e-05	0.00021	CcSEcCtD
Lansoprazole—Arthralgia—Ramipril—type 2 diabetes mellitus	3.65e-05	0.00021	CcSEcCtD
Lansoprazole—Myalgia—Ramipril—type 2 diabetes mellitus	3.65e-05	0.00021	CcSEcCtD
Lansoprazole—Chest pain—Ramipril—type 2 diabetes mellitus	3.65e-05	0.00021	CcSEcCtD
Lansoprazole—Dyspnoea—Losartan—type 2 diabetes mellitus	3.64e-05	0.000209	CcSEcCtD
Lansoprazole—Anxiety—Ramipril—type 2 diabetes mellitus	3.64e-05	0.000209	CcSEcCtD
Lansoprazole—Nausea—Glyburide—type 2 diabetes mellitus	3.63e-05	0.000209	CcSEcCtD
Lansoprazole—Abdominal pain—Metformin—type 2 diabetes mellitus	3.63e-05	0.000209	CcSEcCtD
Lansoprazole—Dizziness—Gliclazide—type 2 diabetes mellitus	3.63e-05	0.000209	CcSEcCtD
Lansoprazole—Somnolence—Losartan—type 2 diabetes mellitus	3.63e-05	0.000208	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	3.62e-05	0.000208	CcSEcCtD
Lansoprazole—Asthenia—Valsartan—type 2 diabetes mellitus	3.62e-05	0.000208	CcSEcCtD
Lansoprazole—Discomfort—Ramipril—type 2 diabetes mellitus	3.6e-05	0.000207	CcSEcCtD
Lansoprazole—Dyspepsia—Losartan—type 2 diabetes mellitus	3.59e-05	0.000206	CcSEcCtD
Lansoprazole—Asthenia—Orlistat—type 2 diabetes mellitus	3.57e-05	0.000206	CcSEcCtD
Lansoprazole—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	3.57e-05	0.000205	CcSEcCtD
Lansoprazole—Pruritus—Valsartan—type 2 diabetes mellitus	3.57e-05	0.000205	CcSEcCtD
Lansoprazole—Dry mouth—Ramipril—type 2 diabetes mellitus	3.57e-05	0.000205	CcSEcCtD
Lansoprazole—Decreased appetite—Losartan—type 2 diabetes mellitus	3.55e-05	0.000204	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	3.54e-05	0.000204	CcSEcCtD
Lansoprazole—Confusional state—Ramipril—type 2 diabetes mellitus	3.53e-05	0.000203	CcSEcCtD
Lansoprazole—Pruritus—Orlistat—type 2 diabetes mellitus	3.53e-05	0.000203	CcSEcCtD
Lansoprazole—Fatigue—Losartan—type 2 diabetes mellitus	3.52e-05	0.000202	CcSEcCtD
Lansoprazole—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000201	CcSEcCtD
Lansoprazole—Oedema—Ramipril—type 2 diabetes mellitus	3.5e-05	0.000201	CcSEcCtD
Lansoprazole—Vomiting—Gliclazide—type 2 diabetes mellitus	3.49e-05	0.000201	CcSEcCtD
Lansoprazole—Pain—Losartan—type 2 diabetes mellitus	3.49e-05	0.0002	CcSEcCtD
Lansoprazole—Constipation—Losartan—type 2 diabetes mellitus	3.49e-05	0.0002	CcSEcCtD
Lansoprazole—Rash—Gliclazide—type 2 diabetes mellitus	3.46e-05	0.000199	CcSEcCtD
Lansoprazole—Dermatitis—Gliclazide—type 2 diabetes mellitus	3.46e-05	0.000199	CcSEcCtD
Lansoprazole—Diarrhoea—Valsartan—type 2 diabetes mellitus	3.45e-05	0.000198	CcSEcCtD
Lansoprazole—Urticaria—Irbesartan—type 2 diabetes mellitus	3.44e-05	0.000198	CcSEcCtD
Lansoprazole—Shock—Ramipril—type 2 diabetes mellitus	3.44e-05	0.000198	CcSEcCtD
Lansoprazole—Headache—Gliclazide—type 2 diabetes mellitus	3.44e-05	0.000198	CcSEcCtD
Lansoprazole—Nervous system disorder—Ramipril—type 2 diabetes mellitus	3.43e-05	0.000197	CcSEcCtD
Lansoprazole—Body temperature increased—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.000197	CcSEcCtD
Lansoprazole—Abdominal pain—Irbesartan—type 2 diabetes mellitus	3.43e-05	0.000197	CcSEcCtD
Lansoprazole—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	3.42e-05	0.000197	CcSEcCtD
Lansoprazole—Tachycardia—Ramipril—type 2 diabetes mellitus	3.41e-05	0.000196	CcSEcCtD
Lansoprazole—Diarrhoea—Orlistat—type 2 diabetes mellitus	3.41e-05	0.000196	CcSEcCtD
Lansoprazole—Skin disorder—Ramipril—type 2 diabetes mellitus	3.4e-05	0.000195	CcSEcCtD
Lansoprazole—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	3.38e-05	0.000194	CcSEcCtD
Lansoprazole—Feeling abnormal—Losartan—type 2 diabetes mellitus	3.36e-05	0.000193	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	3.33e-05	0.000192	CcSEcCtD
Lansoprazole—Dizziness—Valsartan—type 2 diabetes mellitus	3.33e-05	0.000192	CcSEcCtD
Lansoprazole—Anorexia—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000192	CcSEcCtD
Lansoprazole—Dizziness—Orlistat—type 2 diabetes mellitus	3.29e-05	0.000189	CcSEcCtD
Lansoprazole—Asthenia—Metformin—type 2 diabetes mellitus	3.29e-05	0.000189	CcSEcCtD
Lansoprazole—Hypotension—Ramipril—type 2 diabetes mellitus	3.27e-05	0.000188	CcSEcCtD
Lansoprazole—Nausea—Gliclazide—type 2 diabetes mellitus	3.26e-05	0.000187	CcSEcCtD
Lansoprazole—Pruritus—Metformin—type 2 diabetes mellitus	3.25e-05	0.000187	CcSEcCtD
Lansoprazole—Urticaria—Losartan—type 2 diabetes mellitus	3.24e-05	0.000186	CcSEcCtD
Lansoprazole—Abdominal pain—Losartan—type 2 diabetes mellitus	3.22e-05	0.000185	CcSEcCtD
Lansoprazole—Body temperature increased—Losartan—type 2 diabetes mellitus	3.22e-05	0.000185	CcSEcCtD
Lansoprazole—Vomiting—Valsartan—type 2 diabetes mellitus	3.21e-05	0.000184	CcSEcCtD
Lansoprazole—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	3.19e-05	0.000184	CcSEcCtD
Lansoprazole—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	3.19e-05	0.000183	CcSEcCtD
Lansoprazole—Rash—Valsartan—type 2 diabetes mellitus	3.18e-05	0.000183	CcSEcCtD
Lansoprazole—Dermatitis—Valsartan—type 2 diabetes mellitus	3.18e-05	0.000183	CcSEcCtD
Lansoprazole—Vomiting—Orlistat—type 2 diabetes mellitus	3.17e-05	0.000182	CcSEcCtD
Lansoprazole—Insomnia—Ramipril—type 2 diabetes mellitus	3.16e-05	0.000182	CcSEcCtD
Lansoprazole—Headache—Valsartan—type 2 diabetes mellitus	3.16e-05	0.000182	CcSEcCtD
Lansoprazole—Diarrhoea—Metformin—type 2 diabetes mellitus	3.14e-05	0.000181	CcSEcCtD
Lansoprazole—Rash—Orlistat—type 2 diabetes mellitus	3.14e-05	0.000181	CcSEcCtD
Lansoprazole—Paraesthesia—Ramipril—type 2 diabetes mellitus	3.14e-05	0.000181	CcSEcCtD
Lansoprazole—Dermatitis—Orlistat—type 2 diabetes mellitus	3.14e-05	0.00018	CcSEcCtD
Lansoprazole—Headache—Orlistat—type 2 diabetes mellitus	3.12e-05	0.000179	CcSEcCtD
Lansoprazole—Dyspnoea—Ramipril—type 2 diabetes mellitus	3.12e-05	0.000179	CcSEcCtD
Lansoprazole—Asthenia—Irbesartan—type 2 diabetes mellitus	3.11e-05	0.000179	CcSEcCtD
Lansoprazole—Somnolence—Ramipril—type 2 diabetes mellitus	3.11e-05	0.000179	CcSEcCtD
Lansoprazole—Dyspepsia—Ramipril—type 2 diabetes mellitus	3.08e-05	0.000177	CcSEcCtD
Lansoprazole—Pruritus—Irbesartan—type 2 diabetes mellitus	3.07e-05	0.000176	CcSEcCtD
Lansoprazole—Decreased appetite—Ramipril—type 2 diabetes mellitus	3.04e-05	0.000175	CcSEcCtD
Lansoprazole—Dizziness—Metformin—type 2 diabetes mellitus	3.04e-05	0.000175	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	3.02e-05	0.000174	CcSEcCtD
Lansoprazole—Fatigue—Ramipril—type 2 diabetes mellitus	3.01e-05	0.000173	CcSEcCtD
Lansoprazole—Hypersensitivity—Losartan—type 2 diabetes mellitus	3e-05	0.000173	CcSEcCtD
Lansoprazole—Nausea—Valsartan—type 2 diabetes mellitus	3e-05	0.000172	CcSEcCtD
Lansoprazole—Constipation—Ramipril—type 2 diabetes mellitus	2.99e-05	0.000172	CcSEcCtD
Lansoprazole—Diarrhoea—Irbesartan—type 2 diabetes mellitus	2.96e-05	0.00017	CcSEcCtD
Lansoprazole—Nausea—Orlistat—type 2 diabetes mellitus	2.96e-05	0.00017	CcSEcCtD
Lansoprazole—Asthenia—Losartan—type 2 diabetes mellitus	2.93e-05	0.000168	CcSEcCtD
Lansoprazole—Vomiting—Metformin—type 2 diabetes mellitus	2.92e-05	0.000168	CcSEcCtD
Lansoprazole—Rash—Metformin—type 2 diabetes mellitus	2.9e-05	0.000166	CcSEcCtD
Lansoprazole—Dermatitis—Metformin—type 2 diabetes mellitus	2.89e-05	0.000166	CcSEcCtD
Lansoprazole—Pruritus—Losartan—type 2 diabetes mellitus	2.89e-05	0.000166	CcSEcCtD
Lansoprazole—Feeling abnormal—Ramipril—type 2 diabetes mellitus	2.88e-05	0.000166	CcSEcCtD
Lansoprazole—Headache—Metformin—type 2 diabetes mellitus	2.88e-05	0.000165	CcSEcCtD
Lansoprazole—Dizziness—Irbesartan—type 2 diabetes mellitus	2.87e-05	0.000165	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	2.86e-05	0.000164	CcSEcCtD
Lansoprazole—Diarrhoea—Losartan—type 2 diabetes mellitus	2.79e-05	0.00016	CcSEcCtD
Lansoprazole—Urticaria—Ramipril—type 2 diabetes mellitus	2.78e-05	0.00016	CcSEcCtD
Lansoprazole—Abdominal pain—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000159	CcSEcCtD
Lansoprazole—Body temperature increased—Ramipril—type 2 diabetes mellitus	2.76e-05	0.000159	CcSEcCtD
Lansoprazole—Vomiting—Irbesartan—type 2 diabetes mellitus	2.76e-05	0.000158	CcSEcCtD
Lansoprazole—Rash—Irbesartan—type 2 diabetes mellitus	2.73e-05	0.000157	CcSEcCtD
Lansoprazole—Dermatitis—Irbesartan—type 2 diabetes mellitus	2.73e-05	0.000157	CcSEcCtD
Lansoprazole—Nausea—Metformin—type 2 diabetes mellitus	2.73e-05	0.000157	CcSEcCtD
Lansoprazole—Headache—Irbesartan—type 2 diabetes mellitus	2.71e-05	0.000156	CcSEcCtD
Lansoprazole—Dizziness—Losartan—type 2 diabetes mellitus	2.7e-05	0.000155	CcSEcCtD
Lansoprazole—Vomiting—Losartan—type 2 diabetes mellitus	2.59e-05	0.000149	CcSEcCtD
Lansoprazole—Hypersensitivity—Ramipril—type 2 diabetes mellitus	2.58e-05	0.000148	CcSEcCtD
Lansoprazole—Nausea—Irbesartan—type 2 diabetes mellitus	2.57e-05	0.000148	CcSEcCtD
Lansoprazole—Rash—Losartan—type 2 diabetes mellitus	2.57e-05	0.000148	CcSEcCtD
Lansoprazole—Dermatitis—Losartan—type 2 diabetes mellitus	2.57e-05	0.000148	CcSEcCtD
Lansoprazole—Headache—Losartan—type 2 diabetes mellitus	2.55e-05	0.000147	CcSEcCtD
Lansoprazole—Asthenia—Ramipril—type 2 diabetes mellitus	2.51e-05	0.000144	CcSEcCtD
Lansoprazole—Pruritus—Ramipril—type 2 diabetes mellitus	2.47e-05	0.000142	CcSEcCtD
Lansoprazole—Nausea—Losartan—type 2 diabetes mellitus	2.42e-05	0.000139	CcSEcCtD
Lansoprazole—Diarrhoea—Ramipril—type 2 diabetes mellitus	2.39e-05	0.000138	CcSEcCtD
Lansoprazole—Dizziness—Ramipril—type 2 diabetes mellitus	2.31e-05	0.000133	CcSEcCtD
Lansoprazole—Vomiting—Ramipril—type 2 diabetes mellitus	2.22e-05	0.000128	CcSEcCtD
Lansoprazole—Rash—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000127	CcSEcCtD
Lansoprazole—Dermatitis—Ramipril—type 2 diabetes mellitus	2.2e-05	0.000127	CcSEcCtD
Lansoprazole—Headache—Ramipril—type 2 diabetes mellitus	2.19e-05	0.000126	CcSEcCtD
Lansoprazole—Nausea—Ramipril—type 2 diabetes mellitus	2.08e-05	0.000119	CcSEcCtD
Lansoprazole—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	2.93e-06	3.19e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	2.93e-06	3.19e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	2.93e-06	3.19e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	2.93e-06	3.19e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	2.92e-06	3.18e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	2.91e-06	3.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	2.91e-06	3.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.91e-06	3.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	2.9e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	2.89e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	2.89e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	2.89e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—LPL—type 2 diabetes mellitus	2.89e-06	3.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	2.86e-06	3.12e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	2.86e-06	3.12e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	2.86e-06	3.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ADCY5—type 2 diabetes mellitus	2.83e-06	3.08e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	2.82e-06	3.07e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—GPX1—type 2 diabetes mellitus	2.82e-06	3.07e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	2.81e-06	3.06e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—ALB—type 2 diabetes mellitus	2.8e-06	3.05e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	2.79e-06	3.04e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.78e-06	3.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	2.77e-06	3.02e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	2.77e-06	3.02e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	2.77e-06	3.02e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	2.75e-06	2.99e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	2.75e-06	2.99e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CD36—type 2 diabetes mellitus	2.74e-06	2.99e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	2.71e-06	2.96e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.71e-06	2.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	2.71e-06	2.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	2.71e-06	2.95e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	2.71e-06	2.95e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	2.7e-06	2.94e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—PTGS2—type 2 diabetes mellitus	2.69e-06	2.93e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—NOS3—type 2 diabetes mellitus	2.68e-06	2.92e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PIK3R1—type 2 diabetes mellitus	2.68e-06	2.92e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	2.66e-06	2.89e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	2.65e-06	2.88e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	2.63e-06	2.87e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	2.61e-06	2.85e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—MTHFR—type 2 diabetes mellitus	2.6e-06	2.83e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	2.6e-06	2.83e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.6e-06	2.83e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	2.6e-06	2.83e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	2.59e-06	2.82e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	2.58e-06	2.81e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	2.58e-06	2.81e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	2.58e-06	2.81e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARA—type 2 diabetes mellitus	2.55e-06	2.78e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	2.55e-06	2.78e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	2.53e-06	2.76e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.53e-06	2.76e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	2.52e-06	2.75e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	2.52e-06	2.74e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	2.49e-06	2.71e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	2.48e-06	2.71e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	2.48e-06	2.7e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	2.48e-06	2.7e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AGT—type 2 diabetes mellitus	2.47e-06	2.69e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—PTGS2—type 2 diabetes mellitus	2.45e-06	2.67e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	2.45e-06	2.67e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	2.44e-06	2.66e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—CALM1—type 2 diabetes mellitus	2.43e-06	2.65e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOE—type 2 diabetes mellitus	2.42e-06	2.64e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	2.42e-06	2.63e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	2.41e-06	2.62e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—APOA1—type 2 diabetes mellitus	2.39e-06	2.61e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	2.39e-06	2.6e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	2.39e-06	2.6e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	2.39e-06	2.6e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.39e-06	2.6e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	2.39e-06	2.6e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	2.38e-06	2.6e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	2.38e-06	2.59e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	2.37e-06	2.59e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.37e-06	2.58e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	2.37e-06	2.58e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	2.36e-06	2.57e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	2.36e-06	2.57e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	2.35e-06	2.56e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	2.35e-06	2.56e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	2.35e-06	2.56e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	2.34e-06	2.55e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.34e-06	2.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	2.34e-06	2.55e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.33e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.33e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.33e-06	2.54e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	2.32e-06	2.53e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.31e-06	2.52e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	2.31e-06	2.52e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	2.31e-06	2.51e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	2.31e-06	2.51e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	2.28e-06	2.48e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.27e-06	2.48e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	2.27e-06	2.47e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	2.26e-06	2.46e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.26e-06	2.46e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	2.25e-06	2.45e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.25e-06	2.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.25e-06	2.45e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	2.23e-06	2.43e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	2.22e-06	2.42e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.22e-06	2.41e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.21e-06	2.41e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.2e-06	2.39e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	2.19e-06	2.39e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	2.19e-06	2.39e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.17e-06	2.37e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	2.16e-06	2.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.15e-06	2.35e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.13e-06	2.32e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.13e-06	2.32e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.12e-06	2.31e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.11e-06	2.3e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PPARG—type 2 diabetes mellitus	2.11e-06	2.3e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.1e-06	2.29e-05	CbGpPWpGaD
Lansoprazole—CYP4A11—Metabolism—AKT1—type 2 diabetes mellitus	2.1e-06	2.29e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.09e-06	2.27e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.09e-06	2.27e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.09e-06	2.27e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.09e-06	2.27e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	2.08e-06	2.26e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—INS—type 2 diabetes mellitus	2.07e-06	2.25e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.07e-06	2.25e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.05e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.05e-06	2.23e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.04e-06	2.22e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	2.04e-06	2.22e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.03e-06	2.21e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.02e-06	2.2e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.02e-06	2.2e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.02e-06	2.2e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.02e-06	2.2e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.01e-06	2.19e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	1.99e-06	2.17e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	1.99e-06	2.16e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	1.99e-06	2.16e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	1.98e-06	2.16e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.97e-06	2.15e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	1.96e-06	2.13e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	1.96e-06	2.13e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.94e-06	2.11e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	1.94e-06	2.11e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.93e-06	2.11e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	1.93e-06	2.11e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	1.93e-06	2.1e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	1.92e-06	2.09e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.91e-06	2.08e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	1.91e-06	2.08e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	1.9e-06	2.07e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	1.9e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—ALB—type 2 diabetes mellitus	1.9e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	1.89e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	1.89e-06	2.06e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	1.88e-06	2.04e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	1.86e-06	2.03e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	1.84e-06	2.01e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	1.84e-06	2.01e-05	CbGpPWpGaD
Lansoprazole—CYP2C18—Metabolism—AKT1—type 2 diabetes mellitus	1.84e-06	2e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	1.83e-06	1.99e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	1.82e-06	1.98e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.81e-06	1.98e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—NOS3—type 2 diabetes mellitus	1.81e-06	1.98e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	1.81e-06	1.97e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	1.81e-06	1.97e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	1.81e-06	1.97e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	1.81e-06	1.97e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	1.8e-06	1.96e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	1.8e-06	1.96e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	1.8e-06	1.96e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	1.79e-06	1.94e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	1.75e-06	1.91e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	1.74e-06	1.89e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	1.73e-06	1.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	1.73e-06	1.88e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	1.69e-06	1.84e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.68e-06	1.83e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	1.66e-06	1.81e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	1.66e-06	1.81e-05	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—PTGS2—type 2 diabetes mellitus	1.66e-06	1.81e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	1.66e-06	1.81e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.65e-06	1.8e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	1.63e-06	1.77e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	1.59e-06	1.73e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	1.58e-06	1.72e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	1.57e-06	1.71e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.56e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.56e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	1.56e-06	1.7e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.55e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	1.55e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	1.55e-06	1.69e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	1.54e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	1.54e-06	1.68e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.53e-06	1.67e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	1.53e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	1.52e-06	1.66e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	1.51e-06	1.65e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.49e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.48e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.48e-06	1.62e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	1.45e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	1.45e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.45e-06	1.58e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.43e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.42e-06	1.55e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.41e-06	1.54e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.39e-06	1.52e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.39e-06	1.51e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.36e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.36e-06	1.49e-05	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.36e-06	1.48e-05	CbGpPWpGaD
Lansoprazole—CYP1B1—Metabolism—AKT1—type 2 diabetes mellitus	1.35e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.35e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.35e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.35e-06	1.47e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.34e-06	1.46e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.33e-06	1.45e-05	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	1.32e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.32e-06	1.44e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.28e-06	1.39e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.26e-06	1.37e-05	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.25e-06	1.36e-05	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.24e-06	1.35e-05	CbGpPWpGaD
Lansoprazole—ABCG2—Metabolism—AKT1—type 2 diabetes mellitus	1.23e-06	1.34e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.22e-06	1.32e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.21e-06	1.32e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.2e-06	1.3e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.19e-06	1.3e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.18e-06	1.28e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.16e-06	1.26e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.16e-06	1.26e-05	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.06e-06	1.15e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.04e-06	1.13e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.02e-06	1.11e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	9.33e-07	1.02e-05	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	8.92e-07	9.72e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	8.92e-07	9.72e-06	CbGpPWpGaD
Lansoprazole—CYP1A1—Metabolism—AKT1—type 2 diabetes mellitus	8.34e-07	9.08e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	8.16e-07	8.89e-06	CbGpPWpGaD
Lansoprazole—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	7.64e-07	8.32e-06	CbGpPWpGaD
Lansoprazole—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	6.82e-07	7.43e-06	CbGpPWpGaD
Lansoprazole—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	6.66e-07	7.25e-06	CbGpPWpGaD
Lansoprazole—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	6.27e-07	6.83e-06	CbGpPWpGaD
Lansoprazole—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	6.22e-07	6.77e-06	CbGpPWpGaD
Lansoprazole—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	5.32e-07	5.79e-06	CbGpPWpGaD
Lansoprazole—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	4.1e-07	4.47e-06	CbGpPWpGaD
